HIGHLIGHTS
- who: Yegnasew Takele et al. from the Research and Treatment Centre, University of Gondar, Gondar, Ethiopia, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom have published the research work: Impaired in vitro Interferon-u03b3 production in patients with visceral leishmaniasis is improved by inhibition of PD1/PDL-1 ligation, in the Journal: (JOURNAL) of May/30,/2022
- what: The authors aimed to identify which cells express PDL-1; and determine whether the impaired production of IFNu03b3 can be improved by interfering with the PD1/PDL1 pathway. The authors show that at the time of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.